Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
contact us
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
Home
Indication Area
NRT
Pharma
Partners
Team
Newsroom
CONTACT US
Have a Project in Mind? Say Hi!
+1 800 123 456 789
+1 800 123 654 987
Mon - Sun: 10am - 10pm
27 Division St, New York,
NY 10002, USA
grido@mail.com
Home
Blog Listing
Blog Listing
February 24, 2023
Tobacco Reporter
BY
admin
0 COMMENTS
Qnovia Raises $17 million for Nebulizer
March 31, 2023
Bloomberg
BY
admin
0 COMMENTS
Ex-FDA Tobacco Head Advising Company on Smoker Cessation
April 4, 2023
Business Wire
BY
admin
0 COMMENTS
Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor
April 4, 2023
Politico
BY
admin
0 COMMENTS
Former FDA tobacco head: Smokers need a new tool to quit
October 19, 2023
Business Wire
BY
admin
0 COMMENTS
Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases
November 30, 2023
Business Wire
BY
admin
0 COMMENTS
Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy
December 4, 2023
Medical Device Network
BY
admin
0 COMMENTS
Qnovia’s inhaled smoking cessation therapy triumphs in first clinical study
1
…
3
4
5
6
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;}
Qnovia